Form 8-K ANI PHARMACEUTICALS INC For: Aug 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
ANI Pharma (ANIP) Tops Q2 EPS by 34c; Boosts FY16 Outlook
August 4, 2016 8:43 AM EDTANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $1.11, $0.34 better than the analyst estimate of $0.77. Revenue for the quarter came in at $31.34 million versus the consensus estimate of $27.63 million.
GUIDANCE:
ANI Pharma sees FY2016 EPS of $4.00-$4.25, versus the consensus... More



